THE MIRACLE To fully appreciate the importance of antibiotics to everyday life, we must
step back to the edge of the pre-antibiotic era when these lifesaving drugs were first …

Growing antimicrobial resistance and a dwindling antibiotic pipeline have resulted in an
emerging postantibiotic era, as patients are now dying from bacterial infections that were …

The emergence and spread of antibiotic resistant pathogens poses a big challenge to policy-
makers, who need to oversee the transformation of health systems that evolved to provide …

The COVID-19 pandemic has refocused attention worldwide on the dangers of infectious
diseases, in terms of both global health and the effects on the world economy. Even in high …

Today policy makers face the challenge to devise a policy framework that improves orphan
medicinal product (OMP) development by creating incentives to deliver treatments where …

Introduction Neglected diseases are a significant global health challenge. Encouraging the
development of therapeutics and vaccines for these diseases would address an important …

Background To address the growing threat of multidrug-resistant organisms, policymakers
are seeking ideas to promote development of novel antibiotics. In 2018, the REVAMP Act …

The COVID-19 global pandemic has devastated lives and economies. It has served as a
reminder of how critical it is to invest in preventing and treating infectious diseases. Until the …

The European Commission's proposal to address antimicrobial resistance using
transferable exclusivity vouchers (TEVs) is fundamentally flawed. European policymakers …

Two primary regulatory mechanisms have been proposed to incentivize new antibiotic
development:(1) changing Food and Drug Administration (FDA) approval processes to …